(Q40382257)

20 September 2017

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial (English)

1 reference

20 September 2017

3

1 reference

20 September 2017

Björn Holzhauer

6

0 references

Alberto Zanchetti

object named as

Alberto Zanchetti

9

0 references

Giuseppe Mancia

5

object named as

Giuseppe Mancia

1 reference

20 September 2017

1

Sverre E Kjeldsen

1 reference

20 September 2017

4

Franz H Messerli

1 reference

20 September 2017

11

Stevo Julius

1 reference

20 September 2017

Eivind Berge

2

1 reference

20 September 2017

Tsushung A Hua

7

1 reference

20 September 2017

Dion Zappe

8

1 reference

20 September 2017

Michael A Weber

10

1 reference

20 September 2017

29 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

25

1 reference

20 September 2017

2

1 reference

20 September 2017

83-92

1 reference

Antihypertensive therapy and the J-curve: fact or fiction?

20 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment ran

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2015.1106750

10.3109/08037051.2015.1106750

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference